738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia

BACKGROUND: Methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia requires weeks of IV antimicrobial therapy for treatment with antistaphylococcal penicillins (ASP) and first-generation cephalosporins being mainstays of therapy. While effective, use of these agents in the outpatient settin...

Descripción completa

Detalles Bibliográficos
Autores principales: Khodadadi, Ryan B, Yetmar, Zachary A, Go, John R, Chesdachai, Supavit, Razi, Samrah, Abu Saleh, Omar M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751618/
http://dx.doi.org/10.1093/ofid/ofac492.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751618/
http://dx.doi.org/10.1093/ofid/ofac492.029

Ejemplares similares